Oramed Pharmaceuticals Inc (NASDAQ:ORMP)

7.37
Delayed Data
As of Feb 22
 -0.01 / -0.14%
Today’s Change
5.85
Today|||52-Week Range
11.34
-18.11%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 1
2017
Quarter 2
2017
Quarter 3
2017
Quarter 4
2017
Revenue and IncomeNet Revenues611.0K617.0K618.0K611.0K
 
 
 
 
 
Depreciation And Amortization1.0K2.0K1.0K1.0K
 
 
 
 
 
 
Operating ExpensesGross Income--615.0K----
 
 
General Expenses4.0M2.8M3.5M3.3M
 
 
 
 
 
Research And Development3.1M2.3M2.5M2.3M
 
 
 
 
 
Total Operating Expenses4.0M2.8M3.5M3.3M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-3.4M-2.2M-2.9M-2.7M
 
 
 
 
 
Other Expenses-21.0K-20.0K-36.0K-21.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-3.2M-2.0M-2.7M-2.5M
 
 
 
 
 
Net Income-3.2M-2.0M-2.7M-2.5M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS13.3M13.3M13.5M14.2M
 
 
 
 
 
Shares To Calculate EPS Diluted13.3M13.3M13.5M14.2M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.24-$0.15---$0.18
 
 
 
 
EPS Diluted-$0.24-$0.15-$0.20-$0.18